AtaiBeckley clinical pipeline advances toward multiple late-stage data catalysts, Jefferies says

AtaiBeckley Inc. (NASDAQ:ATAI, XETRA:9VC) is moving toward a series of late-stage clinical inflection points in its psychedelic drug pipeline, with multiple...